Paper40323335
Modulation of the PI3K/Akt signaling pathway by resveratrol in cancer: molecular mechanisms and therapeutic opportunity.
Hedayati N and 11 others. Discov Oncol, 2025. Cited by 46 papers, by iCite.
Cite this record
ConductScience Library. Modulation of the PI3K/Akt signaling pathway by resveratrol in cancer: molecular mechanisms and therapeutic opportunity. Papers, record 40323335. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40323335
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Modulation of the PI3K/Akt signaling pathway by resveratrol in cancer: molecular mechanisms and therapeutic opportunity.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References209
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27779703 | Resveratrol induces cell cycle arrest and apoptosis in human eosinophils from asthmatic individuals. | Mol Med Rep | 2016 | https://conductscience.org/library/papers/27779703 | PubMed |
| 2 | 34052324 | Resveratrol for cancer therapy: Challenges and future perspectives. | Cancer Lett | 2021 | https://conductscience.org/library/papers/34052324 | PubMed |
| 3 | 21942447 | Resveratrol modulates MED28 (Magicin/EG-1) expression and inhibits epidermal growth factor (EGF)-induced migration in MDA-MB-231 human breast cancer cells. | J Agric Food Chem | 2011 | https://conductscience.org/library/papers/21942447 | PubMed |
| 4 | 25515619 | Resveratrol induces cell cycle arrest via a p53-independent pathway in A549 cells. | Mol Med Rep | 2015 | https://conductscience.org/library/papers/25515619 | PubMed |
| 5 | 36335870 | Resveratrol inhibits proliferation and induces apoptosis via the Hippo/YAP pathway in human colon cancer cells. | Biochem Biophys Res Commun | 2022 | https://conductscience.org/library/papers/36335870 | PubMed |
| 6 | 29027178 | Mechanisms of regulation of normal and metaplastic intestinal differentiation. | Histol Histopathol | 2018 | https://conductscience.org/library/papers/29027178 | PubMed |
| 7 | 32531316 | Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved. | Arch Biochem Biophys | 2020 | https://conductscience.org/library/papers/32531316 | PubMed |
| 8 | 30946868 | Targeting PI3K signaling in cancer: Challenges and advances. | Biochim Biophys Acta Rev Cancer | 2019 | https://conductscience.org/library/papers/30946868 | PubMed |
| 9 | 33187910 | Oncostatin M: A mysterious cytokine in cancers. | Int Immunopharmacol | 2021 | https://conductscience.org/library/papers/33187910 | PubMed |
| 10 | 26530632 | Resveratrol induces cell cycle arrest in human gastric cancer MGC803 cells via the PTEN-regulated PI3K/Akt signaling pathway. | Oncol Rep | 2016 | https://conductscience.org/library/papers/26530632 | PubMed |
| 11 | 24244343 | Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/β-catenin signal pathway. | PLoS One | 2013 | https://conductscience.org/library/papers/24244343 | PubMed |
| 12 | 23464396 | Resveratrol affects protein kinase C activity and promotes apoptosis in human colon carcinoma cells. | Asian Pac J Cancer Prev | 2012 | https://conductscience.org/library/papers/23464396 | PubMed |
| 13 | 28989978 | The therapeutic potential of resveratrol: a review of clinical trials. | NPJ Precis Oncol | 2017 | https://conductscience.org/library/papers/28989978 | PubMed |
| 14 | 17988825 | Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. | Biomed Pharmacother | 2008 | https://conductscience.org/library/papers/17988825 | PubMed |
| 15 | 16039868 | Rapamycin: an anti-cancer immunosuppressant? | Crit Rev Oncol Hematol | 2005 | https://conductscience.org/library/papers/16039868 | PubMed |
| 16 | 33937049 | Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors. | Front Oncol | 2021 | https://conductscience.org/library/papers/33937049 | PubMed |
| 17 | 20036794 | Inflammation and oncogenesis: a vicious connection. | Curr Opin Genet Dev | 2010 | https://conductscience.org/library/papers/20036794 | PubMed |
| 18 | 17112576 | Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. | Cell | 2006 | https://conductscience.org/library/papers/17112576 | PubMed |
| 19 | 33292283 | Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer. | Cancer Cell Int | 2020 | https://conductscience.org/library/papers/33292283 | PubMed |
| 20 | 35425710 | Nano-Drug Delivery Systems Entrapping Natural Bioactive Compounds for Cancer: Recent Progress and Future Challenges. | Front Oncol | 2022 | https://conductscience.org/library/papers/35425710 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42819232 | Identification of natural TLR4 modulators through network pharmacology and molecular modeling in SARS-CoV-2 Acinetobacter baumannii co-infection. | Front Chem | 2026 | https://conductscience.org/library/papers/42819232 | PubMed |
| 42792182 | Phytochemicals and Irisin as Multi-Target Regulators of Adipose Tissue Browning and Metabolic Reprogramming: Synergies with GLP-1 Pathways. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42792182 | PubMed |
| 42726166 | Dysregulation of the TLR4/MYD88 Signaling Pathway in Egyptian Females with Breast Cancer: Implications for Tumor Progression. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42726166 | PubMed |
| 42643477 | A novel combinatorial therapeutic strategy using resveratrol and viral oncolysis for diffuse intrinsic pontine glioma: an in vitro study. | 3 Biotech | 2026 | https://conductscience.org/library/papers/42643477 | PubMed |
| 42621019 | Neurogenesis and neuroplasticity activities of natural products: therapeutic potential in Alzheimer's disease. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42621019 | PubMed |
| 42588067 | Mechanistic Biological Insights into the Effects of Resveratrol and Nano-Resveratrol on EAT-Induced Hepatorenal Damage. | Nutrients | 2026 | https://conductscience.org/library/papers/42588067 | PubMed |
| 42588034 | Nutraceuticals in Uro-Oncology: A Structured Expert Review and Precision-Oriented Framework. | Nutrients | 2026 | https://conductscience.org/library/papers/42588034 | PubMed |
| 42573911 | Effect of Polyphenols Derived from Medicinal Plants on Multiple Myeloma via Modulating Bone Marrow Microenvironment. | Chin J Integr Med | 2026 | https://conductscience.org/library/papers/42573911 | PubMed |
| 42511744 | Oxyresveratrol Suppresses EGF-Induced AKT Phosphorylation and Reduces Cellular Fitness While Promoting Apoptosis in EGFR-Wild-Type Non-Small Cell Lung Cancer Cells Under EGF Stimulation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511744 | PubMed |
| 42449984 | The Follicular Immune Checkpoint: PD-1/PD-L1 and Immune Tolerance in Oocyte Competence and IVF Failure. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42449984 | PubMed |
| 42416332 | Impact of plant-based interventions on gynecological cancers: a narrative review of mechanistic interplays and clinical evidence. | Front Mol Med | 2026 | https://conductscience.org/library/papers/42416332 | PubMed |
| 42371247 | Epigenetic Regulations by Olive Bioactives: Targeting HDAC for Disease Prevention and Therapy. | Curr Nutr Rep | 2026 | https://conductscience.org/library/papers/42371247 | PubMed |
| 42358819 | Resveratrol in Oral Squamous Cell Carcinoma: Preclinical Evidence and Translational Opportunities. | Oncol Res | 2026 | https://conductscience.org/library/papers/42358819 | PubMed |
| 42196257 | Plant-Derived Bioactive Compounds and Their Therapeutic Potential in Cancer. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196257 | PubMed |
| 42193184 | Anti-Hepatocarcinoma Activity and Mechanism of Isosendanin and Its Novel Structural Analogues Isolated from the Bark of Melia azedarach L.: In Vitro and In Vivo Studies. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42193184 | PubMed |
| 42147231 | Natural supplements in breast cancer therapy: translational evidence, clinical safety, and emerging challenges. | Front Oncol | 2026 | https://conductscience.org/library/papers/42147231 | PubMed |
| 42075806 | Bioactive Natural Compounds in Triple-Negative Breast Cancer: Molecular Targets and Therapeutic Perspectives. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42075806 | PubMed |
| 42016224 | Arachis hypogaea L. Root Extract Mitigates Testosterone Propionate-Induced Benign Prostatic Hyperplasia in ICR Mice by Suppressing Inflammation, Androgen Receptors, and Dihydrotestosterone. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/42016224 | PubMed |
| 41994628 | Advances in polyphenol-based strategies for musculoskeletal recovery and exercise rehabilitation in cancer: Mechanistic insights into Wnt/β-catenin and PI3K/Akt signaling pathways and inflammatory markers. | Front Oncol | 2026 | https://conductscience.org/library/papers/41994628 | PubMed |
| 41888500 | Photobiomodulation at 830 nm with 5 J/cm2 does not promote PI3K/AKT/mTOR signalling pathway activation in hyperglycemic wounded cells. | Lasers Med Sci | 2026 | https://conductscience.org/library/papers/41888500 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| PIK3R1 | 5295 | PubTator's text mining | https://conductscience.org/library/genes/5295 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40323335
GET https://conductscience.org/api/papers/v1/40323335/references?page=2